Young Tongues Fund Launch
Oracle Cancer Trust has partnered up with peer-to-peer support group the Young Tongues to set up the Young Tongues Fund; funding patient support activities led by the Young Tongues, awareness campaigns for Tongue cancer and much needed research that will provide more understanding of Tongue cancer in young patients, how best to treat them and where the greatest unmet needs are.
The Young Tongues are a peer-to-peer support group for Tongue cancer patients and survivors aged 18 – 64. They are a grassroots community that was set up by founder Barbara Fountain, who in 2019 was diagnosed with Squamous Cell Carcinoma of the Tongue. Following a partial glossectomy with forearm free flap and neck dissection she struggled with the impact the diagnosis had on her mental health. The lack of opportunity to connect with individuals of similar age inspired her to set up the Young Tongues in 2021 a global peer-to-peer support group for Tongue cancer patients and survivors aged 18-64. They now support over 350 patients, hold regular virtual and in person meet ups and have a podcast titled “The Young Tongues”. You may also recognise Barbara, as she is a member of our team here at Oracle.
Barbara explains why there was a need for the Young Tongues Fund: “When creating the Young Tongues, I didn’t’ realise how much of a need there was. Two years on and we have over 350 members without doing any large-scale advertising or relationships with health care providers. It made sense to apply to register as a charity and professionalise our services to ensure we have the appropriate safeguarding and organisation in place. As I’ve spent more time within the professional Head and Neck Cancer community, I’ve come to realise that Head and Neck Cancer research is chronically underfunded. So, it didn’t take much to conclude that as a minority patient population, research into Tongue cancer affecting young people wasn’t going to be a top priority. That’s when I realised to create change beyond the support service we offer, we need to look at how we can fund research ourselves. But there was a hitch! I wanted to ensure that the Young Tongues remain administratively small, so we weren’t bogged down by the kind of admin big charities have to contend with, especially as we are a tiny team of volunteers leading this project. It made total sense to partner up with a larger charity who had all the infrastructure in place and expertise when it came to funding research projects. Approaching Oracle was a total no brainer!”
Gemma McKnight, Head of Fundraising and Communications, added: “I’m delighted that we have been able to work with Barbara and her Young Tongues trustees to launch the fund. This fund will benefit survivors, current and future patients of Tongue cancer and the Head and Neck Cancer community more widely.”
If you want to support the Young Tongues Fund click here.
To find out more about the Young Tongues click here.
Or email youngtonguesfund@oraclecancertrust.org for more details.
Cancer Care: Why Mental Health Support Must Be Part of Every Cancer Journey
Oracle Head & Neck Cancer UK is proud to support the Daily Express Cancer Care campaign, a powerful series that shines a light on the often unseen emotional toll of cancer – and the urgent need for better psychological support for everyone affected. The campaign published over the past three weeks featured voices from across…
Ground-breaking blood test shows promise for early detection of head & neck and other hard-to-screen cancers
A new large-scale trial has found that the blood-based screening test known as Galleri test can detect more than 50 types of cancer – including cancers of the head and neck, which currently have no routine screening programme – and may significantly boost early diagnosis. The trial showed that, when used alongside existing screening methods,…
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…